Guidance for the use of substitute prescribing in the treatment of opioid dependence in primary care

Source:
Royal College of General Practitioners - RCGP
Publisher:
Royal College of General Practitioners (RCGP)
Publication date:
01 January 2011

Abstract

Opioid dependence is common in the UK and there are effective substitution medications, including methadone and buprenorphine, to support treatment. This guidance covers the use of substitute medication, which can be an important element in the treatment of opioid dependent patients and their medically assisted recovery (MAR).   These guidelines have been updated in line with "Guidance on methadone and buprenorphine for the management of opioid dependence and drug misuse: opioid detoxification" (NICE 2007) and "Drug misuse and dependence - guidelines for clinical management" (2007). This version combines the previous versions of "Guidance for the use of buprenorphine for the treatment of opoid dependence in primary care" (2004) and " Guidance for the use of methadone for the treatment of opoid dependence in primary care" (2005).